DNAVSHCA• 7 Days (Normalized)
DNA vs HCA (Ginkgo Bioworks Holdings Inc. vs HCA Healthcare Inc.)
Showing Closing Date Range from Sep 29 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $12.41
+3.76%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
HCA Performance $432.2
+0.13%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+3.63 pts
DNA outperforming by 3.63 percentage points
DNAHCA
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | DNA Price | DNA Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $12.41 | +3.76% | $432.20 | +0.13% | +3.63% |
| Oct 05, 2026 | $14.98 | +25.25% | $434.92 | +0.76% | +24.49% |
| Oct 02, 2026 | $12.35 | +3.26% | $426.69 | -1.14% | +4.40% |
| Oct 01, 2026 | $12.50 | +4.52% | $- | - | |
| Sep 30, 2026 | $12.83 | +7.27% | $430.43 | -0.28% | +7.55% |
| Sep 29, 2026 | $11.96 | +0.00% | $431.63 | +0.00% | +0.00% |